share_log

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $14

Chardan Capital Maintains Buy on Coya Therapeutics, Raises Price Target to $14

Chardan Capital維持對Coya Therapeutics的買入,將目標股價上調至14美元
Moomoo 24/7 ·  03/20 05:31

Chardan Capital analyst Keay Nakae maintains Coya Therapeutics (NASDAQ:COYA) with a Buy and raises the price target from $11 to $14.

Chardan Capital分析師Keay Nakae維持Coya Therapeutics(納斯達克股票代碼:COYA)的買入並將目標股價從11美元上調至14美元。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論